This interactive portal improves the analytic experience so you can easily interact with data.
Multi-Study Spotlight: Economic Evaluations of Occupational Health and Safety
Integrated Benefits Institute
Spotlight on article published in
Scandinavian Journal of Work, Environment & Health
IBI Spotlights call attention to important health and productivity findings from peer-reviewed work by external researchers. Unless otherwise stated, the authors are not affiliated with IBI, nor was the research executed on IBI’s behalf. IBI members are encouraged to obtain the original articles from the copyright holder.
What is the Issue?
Economic evaluations of occupational health and safety (OSH) initiatives typically take a societal perspective and include all related costs. Stakeholders such as employers have more limited interests; only costs that impact their enterprise are relevant. The quality of economic evaluations that focus below the societal level is not well known.
What are the findings/solutions?
The overall level of quality of original studies was poor. The authors caution that using results of poorly executed economic evaluations may lead companies to inappropriately allocate OSH resources. Better attention should be paid to the measurement and valuation of costs, sensitivity analyses, and reporting uncertainty around costs and cost-effectiveness estimates.
Journal Citation
Uegaki, K., de Bruijne, M. C., Lambeek, L., Anema, J. R., van der Beek, A. J., van Mechelen, W., & van Tulder, M. W. (2010). Economic evaluations of occupational health interventions from a corporate perspective–a systematic review of methodological quality. Scandinavian journal of work, environment & health, 273-288.
Objectives
To assess the methodological quality of economic evaluations of OSH interventions. By quality it is meant methodological rigor and the relative absence of bias, which limits the usefulness of conclusions and recommendations on which top corporate managers may base decisions to fund OSH programs and services. Previous reviews have found economic evaluations to be of low quality, but these were narrowly focused on the location of treatment or on treatment of particular conditions and suffered from a lack of standardized criteria for assessing quality.
Method
A systematic review of 34 peer-reviewed economic evaluations of OSH interventions. Included studies met seven criteria:
- Study population was working age
- Intervention was workplace or primary care service targeted at workers
- Intervention was compared to an alternative, rather than no treatment
- Outcome was an individual worker’s health-related productive capacity valued in monetary terms
- Costs of intervention were included
- Economic evaluation conducted from a corporate perspective
- Study published in English or Dutch
Interventions were those intended to decrease the risk of health problems, identify at-risk employees, or limit the consequences of diagnosed health problems. Economic evaluations included cost-effectiveness (CE), cost-utility (CU), cost benefit (CB), and financial appraisal (FA) studies. Half the reviewed studies focused on musculoskeletal disorders. Studies were conducted in the US and internationally and represented a diversity of industries. The quality of the evaluations was assessed using a checklist of 19 methodological criteria regarding study design, conduct, analysis and generalizability of findings.
Results
The overall level of quality of original studies was poor. Only 15 of the 34 studies met more than half of the quality criteria. Only three studies met more than three-quarters of the criteria. The least-fulfilled criteria were:
- Declarations of potential conflicts of interest
- Discussions of ethical issues
- Costs measured in proper units
- Costs valued appropriately
- Well-defined, answerable research question posed
- Outcomes measured appropriately
More recent studies tend to be of higher quality than earlier efforts.
Conclusion
The authors caution that using results of poorly executed economic evaluations may lead companies to inappropriately allocate OSH resources. Better attention should be paid to the measurement and valuation of costs, sensitivity analyses, and reporting uncertainty around costs and cost-effectiveness estimates. The checklist questions serve as a resource for improving the quality of research and for raising corporate decisions-makers’ awareness of potential methodological shortcomings in economic evaluations.
- December 2024 (2)
- March 2024 (1)
- January 2024 (1)
- October 2023 (3)
- September 2023 (1)
- July 2023 (1)
- May 2023 (1)
- April 2023 (1)
- February 2023 (1)
- January 2023 (1)
- December 2022 (1)
- November 2022 (1)
- October 2022 (1)
- September 2022 (1)
- August 2022 (2)
- July 2022 (1)
- June 2022 (3)
- May 2022 (2)
- April 2022 (1)
- March 2022 (2)
- February 2022 (1)
- January 2022 (1)
- December 2021 (1)
- November 2021 (1)
- October 2021 (1)
- August 2021 (1)
- July 2021 (2)
- June 2021 (1)
- May 2021 (1)
- April 2021 (1)
- February 2021 (1)
- January 2021 (3)
- August 2020 (1)
- July 2020 (3)
- May 2020 (1)
- April 2020 (4)
- March 2020 (4)
- February 2020 (1)
- January 2020 (1)
- November 2019 (2)
- July 2019 (4)
- June 2019 (3)
- May 2019 (2)
- April 2019 (2)
- March 2019 (3)
- February 2019 (7)
- January 2019 (9)
- November 2018 (6)
- October 2018 (3)
- September 2018 (3)
- August 2018 (2)
- July 2018 (4)
- March 2018 (22)
- February 2018 (1)
- October 2017 (1)
- September 2017 (1)
- August 2017 (1)
- July 2017 (1)
- June 2017 (3)
- May 2017 (2)
- April 2017 (1)
- March 2017 (29)
- February 2017 (1)
- January 2017 (1)
- December 2016 (3)
- November 2016 (2)
- October 2016 (1)
- August 2016 (3)
- May 2016 (2)
- April 2016 (8)
- February 2016 (29)
- January 2016 (1)
- December 2015 (2)
- July 2015 (4)
- June 2015 (6)
- May 2015 (1)
- April 2015 (1)
- March 2015 (22)
- February 2015 (1)
- January 2015 (1)
- December 2014 (1)
- November 2014 (1)
- October 2014 (2)
- September 2014 (1)
- August 2014 (3)
- July 2014 (2)
- June 2014 (1)
- May 2014 (2)
- April 2014 (4)
- March 2014 (8)
- February 2014 (1)
- January 2014 (1)
- December 2013 (2)
- November 2013 (2)
- October 2013 (4)
- August 2013 (1)
- July 2013 (3)
- May 2013 (13)
- March 2013 (2)
- February 2013 (9)
- January 2013 (1)
- December 2012 (1)
- November 2012 (1)
- June 2012 (1)
- May 2012 (1)
- April 2012 (1)
- August 2011 (1)
- June 2011 (3)
- May 2011 (1)
- April 2011 (2)
- March 2011 (1)
- February 2011 (2)
- November 2010 (1)
- October 2010 (1)
- June 2010 (1)
- March 2010 (1)
- January 2010 (2)
- October 2009 (1)
- July 2009 (1)
- May 2009 (2)
- March 2009 (1)
- January 2009 (1)
- November 2008 (1)
- October 2008 (2)
- September 2008 (1)
- August 2008 (1)
- June 2008 (1)
- May 2008 (1)
- April 2008 (2)
- March 2008 (1)
- February 2008 (1)
- January 2008 (2)
- December 2007 (1)
- November 2007 (1)
- October 2007 (1)
- September 2007 (1)
- August 2007 (1)
- July 2007 (1)
- June 2007 (1)
- May 2007 (2)
- March 2007 (1)
- February 2007 (1)
- January 2007 (1)
- August 2006 (1)
- June 2006 (1)
- March 2006 (1)
- May 2005 (1)
- July 2004 (1)
- 2019 (1)
- 2020 (1)
- Absence (2)
- Absence Management (4)
- Article (105)
- Behavioral Health (2)
- Benchmarking (9)
- Benefit Design (11)
- Benefits + Plan Design (26)
- Blog (72)
- Burnout (1)
- Business Performance (2)
- Business Value of Health (21)
- Cancer (3)
- Cardiovascular Disease (4)
- Care Management (1)
- Care Quality (1)
- Caregiving (3)
- Case Studies (7)
- Chronic Conditions (2)
- Communicating H&P to Business Leaders (1)
- Community Health (2)
- Comparative Effectiveness Research (1)
- Connecting HR to Operations (1)
- COVID-19 (13)
- Culture of Health (1)
- Culture of Health + Safety (29)
- Data (1)
- Data Driven Decision Making (1)
- Depression (5)
- Diabetes (5)
- Disability Leave (41)
- Disease Burden (1)
- Employer Perspectives (5)
- Engage Employees (45)
- Event Recap (2)
- Exchanges (4)
- Family + Parental Leave (8)
- FMLA (2)
- Headache (1)
- Health + Productivity Management (54)
- Health Inequities (1)
- Healthcare (2)
- Healthcare Costs (17)
- HPM Survey (3)
- IBI Agenda (2)
- IBI Presents (9)
- immunization (1)
- Industry Profile (1)
- Integrating Health Data (12)
- Invest In Health (52)
- Leave Benchmark Survey (1)
- Linking Health to Business Performance (1)
- Make The Business Case (54)
- Manage Absence (70)
- Market Perspectives (29)
- Maternity (1)
- Measurement (2)
- Measuring Outcomes (21)
- Medication Adherence (1)
- Mental + Emotional Health (15)
- Mental Health (6)
- Migraine (2)
- MSD (1)
- MSK (1)
- Multi-Study Spotlight (23)
- Musc (1)
- Musculoskeletal Disorders (12)
- National Forum (1)
- Obesity (2)
- Occupation (1)
- Online Events (17)
- Pain Management (1)
- Patient Resources (1)
- Patient-Centered (2)
- Pharmacy (5)
- Physical Activity (1)
- Popular and Timely (11)
- Practical Guidance (6)
- Pregnancy (1)
- Presenteeism (1)
- Presenteeism / Job Performance (3)
- Preventive Care (1)
- Previous Forums (109)
- Productivity (46)
- Provider Quality (1)
- Regional Events (1)
- Research (22)
- Research Based Healthcare Evidence (1)
- Research Report (2)
- Research Review (3)
- Return to Work (18)
- Risk Management (11)
- SAW / RTW (1)
- Scholarly Work (2)
- Short-Term Disability (2)
- Sick Leave (15)
- Social Determinants of Health (1)
- Stay at Work (1)
- STD (2)
- Strategies (1)
- Stress (1)
- Suicide (2)
- Surveys (3)
- Talking to Leadership (4)
- Telehealth (3)
- Understand Health Risks (34)
- Value-based Benefit Design (1)
- Vendor Integration (1)
- Video (3)
- virtual care (1)
- virtual health (1)
- Weight Control (5)
- Well-being (15)
- Wellness + Lifestyle (17)
- Working Remotely (4)
- Workplace Culture of Health (2)
- Workplace Health Programs (1)
- Admin
- Brian Gifford
- Brian Gifford Ph.D. Director, Research and Analytics, IBI
- Candace Nelson
- Carole Bonner
- Carolyn Ho
- Carolyn Ho, IBI Communications Lead
- Erin Peterson
- Erin Peterson, Researcher
- Gia Harris
- IBI
- IBI Member
- IBI Research Team
- Integrated Benefits Institute
- Jennifer Santisi
- Jim Huffman
- Kelly McDevitt, IBI President
- Marshall Riddle
- Nicole Nicksic, PhD, MPH Research Lead
- Sera-Leigh Ghouralal
- Thomas Parry, PhD Senior Advisor, Integrated Benefits Institute